pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioPharma Dive·Jun 16·1 min read
save

Express Scripts and PCMA file lawsuits to block Tennessee FAIR Rx Act targeting PBM-owned pharmacies

Jun 16, 2026·read at BioPharma Dive ↗RegulatoryNeutral

Express Scripts, a Cigna subsidiary, and the Pharmaceutical Care Management Association have filed separate lawsuits in federal court in Tennessee.

The suits challenge the FAIR Rx Act, a law passed in May that bars pharmacy benefit managers from owning pharmacies within the state.

The plaintiffs argue the law is unconstitutional and would limit access to prescription medicines for hundreds of thousands of patients by forcing PBM-owned pharmacies to close.

This follows a similar legal action by CVS Caremark earlier this year, indicating a coordinated effort by the PBM industry to overturn the legislation.

source

This writeup was produced by pharmadog from original reporting by BioPharma Dive.

Original headline: “Express Scripts, PCMA sue to block Tennesee law breaking up PBMs and pharmacies”

read at BioPharma Dive ↗
855 words · retrieved Jun 16
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 2h agoAn AI drug specialist zeroes in on rare forms of obesityBioPharma Dive
  • 2h agoGSK wagers up to $1.3B on a different kind of cancer drugBioPharma Dive
  • 3h agoUltragenyx to weigh ‘significant’ cost cuts as Angelman drug fails key studyBioPharma Dive
  • 5h agoAkeso, Summit cancer drug confirms lung cancer survival benefitBioPharma Dive
  • 6h agoThe hidden scale-out problem behind CAR-T’s growthBioPharma Dive